World
Emmes (CRO) Acquires Clinical Edge
- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical in...
September 30, 2022 | News
Pall Corporation Launches Three New Allegro™ Connect Systems
Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...
September 28, 2022 | News
Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...
September 27, 2022 | News
Sciwind Biosciences and SynerK Enter into Research Partnership
The partnership combines Sciwind's expertise in disease biology and clinical development capabilities with SynerK's proprietary conjugate-based siRNA deliv...
September 27, 2022 | News
Biocytogen Expands Partnership with Merck
Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...
August 29, 2022 | News
Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities
Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...
August 24, 2022 | News
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapi...
August 23, 2022 | News
BD, Accelerate Diagnostics Announce Global Commercial Collaboration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ:...
August 15, 2022 | News
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...
August 09, 2022 | News
Seegene unveils strategies for global expansion at 2022 AACC
Company has taken part in the Annual Scientific Meeting & Clinical Lab Expo since 2007 This year's event showcased its In-life PCR campaig...
August 01, 2022 | News
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney
The consortium partnership strives to advance a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants...
July 27, 2022 | News
CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President
CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today...
July 26, 2022 | News
Vaccines alone aren't enough to combat AMR, claims new WHO report
A recent report published by the World Health Organization (WHO) identified vaccines as "highly effective tools in combating AMR". Despite their ...
July 25, 2022 | News
BD Completes Acquisition of Parata Systems
BD enters growing pharmacy automation market segment by offering a comprehensive set of technologies across the care continuum - Addition of Pa...
July 18, 2022 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
